- Conditions
- Primary Amenorrhea With Hypogonadotropic Hypogonadism
- Interventions
- Gonadorelin acetate subcutaneous (SC) 10 μg/pulse as a fixed dose, administered via. OmniPod pump, Gonadorelin acetate SC 15 μg/pulse as a fixed dose, administered via. OmniPod pump, Gonadorelin acetate SC 20 μg/pulse as a fixed dose, administered via. OmniPod pump, Placebo (SC 10, 15, or 20 μg/pulse as a fixed dose, administered via. OmniPod pump)
- Drug
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 33
- States / cities
- Tempe, Arizona • San Francisco, California • Aurora, Colorado + 28 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 67
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Infertility
- Interventions
- HCG, Lupron Trigger, Dual Trigger
- Drug
- Lead sponsor
- Weill Medical College of Cornell University
- Other
- Eligibility
- 21 Years to 55 Years · Female only
- Enrollment
- 26 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2016
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Pregnancy Prevention
- Interventions
- Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo
- Drug · Other
- Lead sponsor
- InnovaGyn, Inc.
- Other
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 21 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Raleigh, North Carolina
- Conditions
- Compare Pregnancy Rates Between FSH Stimulation and FSH and, GnRH Antagonist
- Interventions
- Follistim administration, Follistim plus Ganirelix
- Drug
- Lead sponsor
- Houston Fertility Institute
- Other
- Eligibility
- 18 Years to 39 Years · Female only
- Enrollment
- 80 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Acupuncture, Sham Acupuncture
- Procedure
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 18 Years to 43 Years · Female only
- Enrollment
- 78 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Polycystic Ovary Syndrome, Anovulation, Oligoovulation, Infertility, Hyperandrogenism
- Interventions
- Metformin, Clomiphene citrate, Placebo
- Drug
- Lead sponsor
- 59th Medical Wing
- Federal
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 56 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 1997 – 2003
- U.S. locations
- 1
- States / cities
- Lackland Air Force Base, Texas
- Conditions
- Pregnancy
- Interventions
- Knowing your body, Healthy Lifestyle
- Other · Behavioral
- Lead sponsor
- Calvin College
- Other
- Eligibility
- 18 Years to 44 Years · Female only
- Enrollment
- 120 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2017
- U.S. locations
- 1
- States / cities
- Grand Rapids, Michigan
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Not listed
- Lead sponsor
- Georgia Reproductive Specialists
- Other
- Eligibility
- 18 Years to 55 Years · Female only
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Ovulation
- Interventions
- NES/E2 gel
- Drug
- Lead sponsor
- Population Council
- Other
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2014
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Menstrual Cycle, Ovulation, Menstruation, Polycystic Ovary Syndrome, Infertility, Menopause, Reproduction, Reproductive Health
- Interventions
- Not listed
- Lead sponsor
- Apple Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 500,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2029
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Menstruation, Ovulation
- Interventions
- Not listed
- Lead sponsor
- Fitbit LLC
- Industry
- Eligibility
- 18 Years to 42 Years · Female only
- Enrollment
- 143 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Polycystic Ovarian Syndrome
- Interventions
- Raloxifene, Clomiphene
- Drug
- Lead sponsor
- Bruce Lessey
- Other
- Eligibility
- 18 Years to 36 Years · Female only
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Greenville, South Carolina
- Conditions
- Suppression of Ovulation
- Interventions
- Nestorone®/Estradiol Contraceptive Vaginal Ring
- Device
- Lead sponsor
- Premier Research
- Other
- Eligibility
- 18 Years to 39 Years · Female only
- Enrollment
- 65 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2017
- U.S. locations
- 7
- States / cities
- Sacramento, California • New York, New York • Cincinnati, Ohio + 4 more
- Conditions
- Pregnancy, Contraception
- Interventions
- TV-46046 - 400 mg/mL, TV-46046 - 200 mg/mL
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2018
- U.S. locations
- 2
- States / cities
- Philadelphia, Pennsylvania • Norfolk, Virginia
- Conditions
- Fertility
- Interventions
- Kegg
- Device
- Lead sponsor
- Lady Technologies Inc
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 500 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Progesterone Vaginal Gel 8%, Letrozole Oral Tablet, pelvic ultrasound, Ovidrel 250 MCG Per 0.5 ML Prefilled Syringe, Intrauterine insemination or timed intercourse
- Drug · Diagnostic Test · Other
- Lead sponsor
- Eastern Virginia Medical School
- Other
- Eligibility
- 20 Years to 40 Years · Female only
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 1
- States / cities
- Norfolk, Virginia
- Conditions
- Premature Ovarian Failure
- Interventions
- Estradiol/Medroxyprogesterone acetate
- Drug
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 18 Years to 40 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2011
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Focus: Estrogen-free Oral Contraception
- Interventions
- Ulipristal Acetate
- Drug
- Lead sponsor
- Premier Research
- Other
- Eligibility
- 18 Years to 35 Years · Female only
- Enrollment
- 180 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 10
- States / cities
- Los Angeles, California • San Francisco, California • Aurora, Colorado + 6 more
- Conditions
- Pregnancy Prevention
- Interventions
- Levonorgestrel 0.15 milligram, Meloxicam 15 milligram, calcium carbonate 750 milligram
- Drug · Other
- Lead sponsor
- InnovaGyn, Inc.
- Other
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Raleigh, North Carolina
- Conditions
- Epilepsy
- Interventions
- Not listed
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 199 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2015
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts • Great Neck, New York • New York, New York
- Conditions
- Infertility, Decreased Ovarian Reserve
- Interventions
- Dehydroepiandrosterone
- Dietary Supplement
- Lead sponsor
- Center for Human Reproduction
- Other
- Eligibility
- 40 Years to 45 Years · Female only
- Enrollment
- 8 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- PCOS, Sleep Apnea
- Interventions
- Screening for obstructive sleep apnea, CPAP - continuous positive airway pressure
- Other · Device
- Lead sponsor
- University of South Florida
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 4 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2017
- U.S. locations
- 6
- States / cities
- Lakeland, Florida • Sarasota, Florida • St. Petersburg, Florida + 2 more
- Conditions
- Polycystic Ovary Syndrome, Infertility, Female
- Interventions
- May Health System
- Device
- Lead sponsor
- May Health
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 195 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2029
- U.S. locations
- 24
- States / cities
- Encino, California • San Francisco, California • Clearwater, Florida + 21 more
- Conditions
- Autoimmune Disease, Infertility, Premature Ovarian Failure
- Interventions
- Not listed
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 18 Years to 39 Years · Female only
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1992 – 2011
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland